ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2319

Reducing selection bias while maintaining precision through an integrated analysis: 2-year longitudinal analysis of imaging outcomes in the SPondyloArthritis Caught Early cohort

Liese de Bruin1, Floris A. van Gaalen1, Manouk de Hooge2, Miranda van Lunteren1, Mary Lucy Marques3, Monique Reijnierse4, Roberta Ramonda5, Inger Jorid Berg6, Carl Turesson7, Robert Landewé8, Désirée Van Der Heijde1 and Sofia Ramiro9, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Department of Rheumatology, Ghent University Hospital, Ghent, Belgium, 3Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands; and Coimbra Local Health Unit, Coimbra, Portugal, 4Department of Radiology, Leiden University Medical Center, Leiden, Netherlands, 5Rheumatology Unit-DIMED-University of Padova ITALY, Padova, Padua, Italy, 66Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Nepal, 7Lund University, Malmö, Sweden, 8Department of Rheumatology, Amsterdam University Medical Center, Amsterdam, Netherlands; and Zuyderland Medical Center, Heerlen, Netherlands, 9Leiden University Medical Center, Bunde, Netherlands

Meeting: ACR Convergence 2025

Keywords: Imaging, longitudinal studies, spondyloarthritis, Statistical methods

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2305–2337) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Imaging outcomes in ongoing cohort studies are typically evaluated across multiple reading rounds by several readers. Often, only scores from the most recent reading round are used, disregarding valuable data from previous rounds and potentially introducing selection bias by excluding participants lost to follow-up. Using an integrated analysis is an alternative incorporating scores from multiple readers and rounds. This method provides a more truthful reflection, but may introduce additional variability, potentially reducing the estimates’ precision. Therefore, we assessed if an integrated analysis, using available imaging data over time from different reading rounds, affects the precision of change estimates in early axSpA, using a completers analysis as reference.

Methods: Patients with chronic back pain (≥3 months; ≤2 years; onset < 45 years) from the SPondyloArthritis Caught Early cohort with a rheumatologist’s diagnosis of axSpA after two years of follow-up were included. MRIs and radiographs of the sacroiliac joints (SIJ) and spine obtained at baseline, 3 months, 1 and 2 years of follow-up were scored for inflammatory and structural lesions by ≥2 readers in two reading rounds: in round A, baseline, 3 months and 1 year were scored; in round B, baseline, 3 months, 1 and 2 years were scored. Change of each imaging outcome over time was analyzed with multilevel generalized estimating equations (considering the reader level), with time as explanatory variable. Two approaches were used: i) ‘integrated analysis’ (patients with ≥1 score from ≥1 reader from ≥1 reading round); ii) ‘completers-only analysis’ (patients with ≥1 score from ≥1 reader from round B at 2-year follow-up). The second and commonly used approach was considered the reference. We tested different time transformations to investigate which yielded the lowest quasi-likelihood under the independence model criterion, and the best model fit. In cases of comparable fit, the model with the simplest time format was chosen.

Results: In total, we analyzed 332 patients with axSpA (mean age 30 (SD 8) years; 53% males) of which 279 (84%) patients were included in the completers-only analysis. Binary and continuous variables for inflammatory lesions decreased over time in the MRI of the SIJ and spine, while structural lesions increased (Tables 1 and 2). Due to the best or very comparable fit, models with a linear time representation were used for all outcomes.Comparing both analyses, the integrated analysis included more patients but with similar levels of precision of the change estimates as the completers-only analysis for both the binary and continuous variables. Particularly for binary outcomes, a similar change was found by the integrated analysis with more precision compared to the completers-only analysis, e.g. sacroiliitis according to the ASAS criteria [estimated yearly % change (95% CI): -5.57 (-8.31; -2.83) vs -5.78 (-8.57; -2.99)].

Conclusion: In this longitudinal study, the integrated analysis was shown to allow for the inclusion of all available data, thereby reducing selection bias in determining the population for analysis, while maintaining precision of change estimates in patients with early axSpA.

Supporting image 1

Supporting image 2


Disclosures: L. de Bruin: None; F. van Gaalen: AbbVie, 2, BMS, 2, Eli Lilly, 2, Jacobus Stichting, 5, MSD, 2, Novartis, 2, 5, Stichting ASAS, 5, Stichting vrienden van Sole Mio, 5, UCB, 5; M. de Hooge: UCB pharma, 2; M. van Lunteren: None; M. Marques: Novartis, 2, 6; M. Reijnierse: None; R. Ramonda: None; I. Berg: None; C. Turesson: AbbVie/Abbott, 1, 6, Nordic Drugs, 2, 6, Novartis, 1, 6; R. Landewé: AbbVie/Abbott, 2, Bristol-Myers Squibb(BMS), 2, Eli Lilly, 2, Janssen, 2, Joint Imaging BV, 12, Director, Novartis, 2, Pfizer, 2, Rheumatology Consultancy BV, 12, Director, UCB, 2; D. Van Der Heijde: AbbVie, 2, Alfasigma, 2, Annals of the Rheumatic Diseases, 12, Associate editor, ArgenX, 2, Bristol Myers Squibb, 2, Eli Lilly and Company, 2, Grey-Wolf Therapeutics, 2, Imaging Rheumatology BV, 12, Director, Janssen, 2, Journal of Rheumatology, 12, Editorial board member, Novartis, 2, Pfizer, 2, RMD Open, 12, Editoral board member, Takeda, 2, UCB, 2; S. Ramiro: AbbVie, 2, 5, Eli Lilly, 2, 5, Galapagos/Alfasigma, 2, 5, Janssen, 2, MSD, 2, 5, Novartis, 2, 5, Pfizer, 2, 5, Sanofi, 2, 5, UCB, 2, 5.

To cite this abstract in AMA style:

de Bruin L, van Gaalen F, de Hooge M, van Lunteren M, Marques M, Reijnierse M, Ramonda R, Berg I, Turesson C, Landewé R, Van Der Heijde D, Ramiro S. Reducing selection bias while maintaining precision through an integrated analysis: 2-year longitudinal analysis of imaging outcomes in the SPondyloArthritis Caught Early cohort [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/reducing-selection-bias-while-maintaining-precision-through-an-integrated-analysis-2-year-longitudinal-analysis-of-imaging-outcomes-in-the-spondyloarthritis-caught-early-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reducing-selection-bias-while-maintaining-precision-through-an-integrated-analysis-2-year-longitudinal-analysis-of-imaging-outcomes-in-the-spondyloarthritis-caught-early-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology